Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet.

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

Say what you will about Bungie, but it does like to try and shake up big parts of the core Destiny 2 experience from time to time. And, after slowly diminishing the number of bounty-carrying vendors, ...

The new Disney Destiny is on its way to Florida ahead of its maiden cruise, which is scheduled for late November. Built at the Meyer Werft shipyard in Germany, the newbuild was delivered to Disney ...

One of the yearly events for Destiny 2 is Festival of the Lost. The Halloween-themed event has returned, but with two new game modes. Both PvE and PvP fans can rejoice. Bungie has made a couple of ...

Since Destiny 2’s Edge of Fate expansion launched to tepid critical reception and overwhelmingly grumpy player sentiment, it’d be fair to say that Bungie has been doing its best to walk back some of ...

ATLANTA — Atlanta United CEO Garth Lagerwey announced Tuesday night that he will take another leave of absence to focus on his cancer treatment. Lagerwey revealed his cancer diagnosis in July and ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

Destiny 2‘s annual Halloween event, Festival of the Lost, has returned, bringing with it a bunch of new weapons and other rewards to chase, including an SMG that has incredible perks. This year, ...

ATLANTA (AP) — Atlanta United president and chief executive officer Garth Lagerwey is taking a leave of absence to focus on his cancer treatment and recovery, the team announced on Tuesday.

Ray's arrival at a bunker disrupts Major Cross's team guarding a captured vampire queen. His presence tests loyalties as medical officer Starling and scientist Davis face decisions that could ...

T-DXd plus THP achieved a higher pCR rate (67.3%) than ddAC-THP (56.3%) in high-risk, HER2-positive early breast cancer. The trial demonstrated improved efficacy and safety for T-DXd plus THP, with ...